Metropolis Healthcare’s board approves acquisition of Hitech Diagnostic Centre and its subsidiary

16 Oct 2021 Evaluate

Metropolis Healthcare’s board has approved the acquisition of Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services for a cash consideration of Rs 636 crore. The company's board had earlier approved the acquisition partly by cash consideration of Rs 511 crore and equity consideration of up to 4,95,000 fully paid-up equity shares of Rs 2 each.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1737.50 0.10 (0.01%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 520.80
Apollo Hospital Ent. 6152.25
Max Healthcare Inst 775.85
Narayana Hrudayalay 1246.20
Global Health 1399.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.